P12.04.A CAR-ENGINEERED PRIMARY NK CELLS SHOW PROMISING EFFECTS AS TARGETED THERAPY AGAINST EGFR-POSITIVE GLIOBLASTOMA
P12.04.A CAR 工程化原代 NK 细胞作为靶向治疗 EGFR 阳性胶质母细胞瘤显示出良好的效果
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024024952
Srinagesh, Hrishikesh; Jackson, Clayton; Shiraz, Parveen; Jeyakumar, Nikeshan; Hamilton, Mark; Egeler, Emily; Mavroukakis, Sharon; Kuo, Adam; Cancilla, Juancarlos; Sahaf, Bita; Agarwal, Neha; Kanegai, Alyssa; Kramer, Anne Marijn; Arai, Sally; Bharadwaj, Sushma; Dahiya, Saurabh; Hosoya, Hitomi; Johnston, Laura; Kennedy, Vanessa; Liedtke, Michaela; Lowsky, Robert; Mikkilineni, Lekha; Negrin, Robert; Rezvani, Andrew; Sidana, Surbhi; Shizuru, Judith; Smith, Melody; Weng, Wen-Kai; Feldman, Steven; Frank, Matthew J; Lee, Zachary; Tagliaferri, Mary; Marcondes, A Mario; Miklos, David; Mackall, Crystal; Muffly, Lori; Lysinger, A S; Salvador, E; Vormwald, L; Ernestus, R; Löhr, M; Hagemann, C; Roller, B; Reindl, L; Strassheimer, F; Ziegener, L; Elleringmann, P; Kiefer, A; Röder, J; Steinbach, J; Wels, W; Ullrich, E; Burger, M
